Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Envelope protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Exosomal vaccine
Envelope protein
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/29/2022
LSNME/SW1
Envelope protein
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/01/2021
Chloroquine phosphate
Envelope protein
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
Envelope protein
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
17-alpha-Hydroxywithanolide D
Envelope protein
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Withanolide R
Envelope protein
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
6-Thioguanosine 5'-diphosphate
Envelope protein
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Coagulin Q
Envelope protein
Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021
Tretinoin
Envelope protein
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
RQ3013-VLP
Envelope protein
Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020
Gliclazide
Envelope protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/20/2020
Memantine
Envelope protein
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/20/2020